This difference was not quite significant at the two year follow-up.
← all excerpts
Bevacizumab as an Adjunct to Trabeculectomy in Primary Open-Angle Glaucoma: A Randomized Trial.
1
—
—
This difference was not quite significant at the two year follow-up.